Palipase MT-20 20,000 UNT / 56,000 UNT / 44,000 UNT Delayed Release Oral Capsule
RxNorm 809262
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 809262 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Palipase MT-20 20,000 UNT / 56,000 UNT / 44,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 56000 UNT / lipase 20000 UNT / protease 44000 UNT Delayed Release Oral Capsule [Palipase]
(Atom ID: 12361143)
SY
Synonym (SY):
Palipase (amylases 56,000 UNT / endopeptidases 44,000 UNT / lipase 20,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845948)
SY
Synonym (SY):
Palipase MT 20 (amylase 56,000 UNT / lipase 20,000 UNT / protease 44,000) Delayed Release Oral Capsule
(Atom ID: 11845947)
SY
Synonym (SY):
Palipase MT 20 Delayed Release Oral Capsule
(Atom ID: 6339253)
PSN